UB Paderborn / Katalog / Suche / in CDI

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Blood, 2022-03, Vol.139 (10), p.1452-1468

2022

Volltextzugriff (PDF)

Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study

Critical care medicine, 2022-01, Vol.50 (1), p.81

2022

Volltextzugriff (PDF)

Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation

Journal of the American Academy of Dermatology, 2020-09, Vol.83 (3), p.762-772

2020

Volltextzugriff (PDF)

Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival

JNCI : Journal of the National Cancer Institute, 2018-11, Vol.110 (11), p.1248-1258

2018

Volltextzugriff (PDF)

Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant

Bone marrow transplantation (Basingstoke), 2020-01, Vol.55 (1), p.77-85

2020

Volltextzugriff (PDF)

Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors

Transplantation and cellular therapy, 2024-08, Vol.30 (8), p.808.e1-808.e13

2024

Volltextzugriff (PDF)

Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant

Bone marrow transplantation (Basingstoke), 2020-01, Vol.55 (1), p.272-272

2020

Volltextzugriff (PDF)

β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD

JCI insight, 2020-06, Vol.5 (12)

2020

Volltextzugriff (PDF)

Histopathology and SARS-CoV-2 Cellular Localization in Eye Tissues of COVID-19 Autopsies

The American journal of pathology, 2023-11, Vol.193 (11), p.1809-1816

2023

Volltextzugriff (PDF)

Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma

Cancer causes & control, 2012-07, Vol.23 (7), p.1017-1029

2012

Volltextzugriff (PDF)

Age, Sex and Self-Reported Race Differences in Immune Profiles of Hematologic Malignancy Patients

Blood, 2021-11, Vol.138 (Supplement 1), p.4066-4066

2021

Volltextzugriff (PDF)

Risk Factors for the Development of Cutaneous Melanoma after Allogeneic Hematopoietic Cell Transplantation

Blood, 2018-11, Vol.132 (Supplement 1), p.249-249

2018

Volltextzugriff (PDF)

Outcomes of HLA-Matched Related Donor (MRD) and Haploidentical Donor (Haplo) Allogeneic Hematopoietic Cell Transplant Recipients By Immune Profiles of Recipients and Donors

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S229-S230

2023

Volltextzugriff (PDF)

300 - Outcomes of HLA-Matched Related Donor (MRD) and Haploidentical Donor (Haplo) Allogeneic Hematopoietic Cell Transplant Recipients By Immune Profiles of Recipients and Donors

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.S229-S230

2023

Volltextzugriff (PDF)

Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma

Blood, 2014-08, Vol.124 (8), p.1259-1265

2014

Volltextzugriff (PDF)

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

Leukemia & lymphoma, 2016-03, Vol.57 (3), p.635-643

2016

Volltextzugriff (PDF)

Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score

Biology of blood and marrow transplantation, 2020-11, Vol.26 (11), p.e271

2020

Volltextzugriff (PDF)

Abstract 1894: Early adulthood sun exposure, vitamin D related gene variants, and risk of non-Hodgkin lymphoma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1894-1894

2011

Volltextzugriff (PDF)

Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell-Associated Encephalopathy (ICE) Score

Biology of blood and marrow transplantation, 2020-11, Vol.26 (11), p.e271-e274

2020

Volltextzugriff (PDF)

Archaeology in Jordan, 2006 Season

American journal of archaeology, 2007-07, Vol.111 (3), p.523-547

2007

Volltextzugriff (PDF)

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

Leukemia & Lymphoma, 2016, Vol.57 (3), p.635-643

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study

Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation

Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival

The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities

Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant

Outcomes of Human Leukocyte Antigen-Matched Related Donor and Haploidentical Allogeneic Hematopoietic Cell Transplantation Recipients by Immune Profiles of Recipients and Donors

Correction: Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant

β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD

Histopathology and SARS-CoV-2 Cellular Localization in Eye Tissues of COVID-19 Autopsies

Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma

Age, Sex and Self-Reported Race Differences in Immune Profiles of Hematologic Malignancy Patients

Risk Factors for the Development of Cutaneous Melanoma after Allogeneic Hematopoietic Cell Transplantation

Outcomes of HLA-Matched Related Donor (MRD) and Haploidentical Donor (Haplo) Allogeneic Hematopoietic Cell Transplant Recipients By Immune Profiles of Recipients and Donors

300 - Outcomes of HLA-Matched Related Donor (MRD) and Haploidentical Donor (Haplo) Allogeneic Hematopoietic Cell Transplant Recipients By Immune Profiles of Recipients and Donors

Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell Encephalopathy (ICE) Score

Redox Associated Gene Expression Predicts For Responses To The Pro-Oxidant Molecule Imexon In Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma: Results Of a Multi-Center Phase II Study

Abstract 1894: Early adulthood sun exposure, vitamin D related gene variants, and risk of non-Hodgkin lymphoma

Identification of Neurotoxicity after Chimeric Antigen Receptor (CAR) T Cell Infusion without Deterioration in the Immune Effector Cell-Associated Encephalopathy (ICE) Score

Archaeology in Jordan, 2006 Season

Phase 1 trial of carfilzomib (PR-171) in combination with vorinostat (SAHA) in patients with relapsed or refractory B-cell lymphomas

Suchergebnisse filtern